Young Patient Ischemic Stroke Protocol
Young patients with acute ischemic stroke should be managed with the same aggressive time-dependent protocols as older adults, including immediate evaluation for IV tPA within 3-4.5 hours and consideration for mechanical thrombectomy within 6 hours for large vessel occlusions. 1
Immediate Assessment and Stabilization
Time-Critical Evaluation
- Treat stroke as a life-threatening emergency requiring immediate action - the goal is door-to-tPA time of ≤60 minutes 1
- Establish exact time of symptom onset or last known normal time, as this determines all treatment eligibility 2
- Perform urgent non-contrast CT or MRI to differentiate ischemic from hemorrhagic stroke and assess for contraindications to thrombolysis 1
- Calculate NIHSS score immediately to quantify stroke severity and guide treatment decisions 1
Airway, Breathing, and Circulation
- Provide supplemental oxygen only if oxygen saturation is <94% or unknown - routine oxygen is not recommended 2
- Maintain airway patency, particularly in patients with decreased consciousness or severe deficits 1
- Do NOT aggressively lower blood pressure unless systolic BP >185/110 mmHg before tPA or >180/105 mmHg after tPA - permissive hypertension improves cerebral perfusion 1, 2
- Check blood glucose immediately, as hypoglycemia can mimic stroke symptoms 2
Thrombolytic Therapy (IV tPA)
Within 3 Hours of Symptom Onset
Administer IV alteplase 0.9 mg/kg (maximum 90 mg) with 10% as bolus and 90% infused over 1 hour - this is a Level A recommendation with the strongest evidence for improved functional outcomes 1
- Favorable outcomes achieved in 31-50% of tPA-treated patients versus 20-38% with placebo 1
- Earlier treatment within 90 minutes yields even better outcomes (OR 2.81 for favorable outcome) 1
- Symptomatic hemorrhage risk is 6.4% versus 0.6% with placebo, but mortality rates are similar 1
Between 3-4.5 Hours of Symptom Onset
Consider IV tPA using ECASS III criteria - this is a Level B recommendation based on the ECASS III trial showing 52.4% excellent outcomes versus 45.2% with placebo 1
Additional exclusion criteria for the 3-4.5 hour window:
- Age >80 years
- NIHSS score >25
- Any oral anticoagulant use (regardless of INR)
- Combined history of both prior stroke AND diabetes 1
Critical tPA Management Points
- Symptomatic hemorrhage occurs in 2.4% in the 3-4.5 hour window 1
- Do NOT delay tPA to wait for endovascular therapy availability - observing for clinical response before pursuing thrombectomy is not recommended 1
- Administer aspirin 160-325 mg within 24-48 hours AFTER tPA (not before or during) 1, 3
- No heparin, warfarin, or other antithrombotics for 24 hours post-tPA 1
Mechanical Thrombectomy (Endovascular Treatment)
Indications for Thrombectomy in Young Patients
Strongly consider mechanical thrombectomy with stent retrievers for patients meeting ALL criteria: 1
- Age ≥18 years (though case reports show benefit in younger patients, randomized data are lacking) 1
- Pre-stroke mRS score 0-1 (functionally independent)
- ICA or proximal MCA (M1) occlusion confirmed on imaging
- NIHSS score ≥6
- ASPECTS ≥6 on non-contrast CT
- Groin puncture achievable within 6 hours of symptom onset
- TICI 2b/3 reperfusion achieved as the technical goal 1
Thrombectomy Evidence and Outcomes
- Stent retriever trials showed 43.7% good outcomes (mRS 0-2) with thrombectomy versus 28.2% with medical therapy alone (adjusted OR 2.1) 1
- Recanalization rates of 66% with modern stent retrievers versus 27-41% with older devices 1
- Use stent retrievers preferentially over older MERCI devices (Class I recommendation) 1
- Consider proximal balloon guide catheter or large-bore distal access catheter to improve recanalization rates 1
Special Considerations for Young Patients
While no randomized trials exist specifically for patients <18 years, case reports demonstrate high recanalization rates and favorable outcomes with endovascular therapy in young patients 1. However, diagnostic delays are common in pediatric stroke (median 8.8-16 hours to imaging), making time-sensitive interventions challenging 1.
Post-Acute Management
Monitoring Protocol
For tPA-treated patients: 1
- Neurological assessment and vital signs every 15 minutes for 2 hours, then every 30 minutes for 6 hours, then hourly for 16 hours
- Continuous cardiac monitoring for up to 72 hours
- Monitor for bleeding complications continuously
- Temperature every 4 hours; treat fever >99.6°F with acetaminophen 1
For non-thrombolyzed patients: 1
- Neurological checks and vital signs every 4 hours minimum in non-ICU settings
- Continuous cardiac monitoring for 24-48 hours
- Start antiplatelet therapy within 24 hours of admission 1
Antiplatelet Therapy for Non-Thrombolyzed Patients
Administer aspirin 160-325 mg within 48 hours of stroke onset - this provides modest benefit with reasonable safety 1, 3
For long-term secondary prevention in noncardioembolic stroke, the American College of Chest Physicians recommends aspirin 50-100 mg daily, aspirin/extended-release dipyridamole 25/200 mg twice daily (preferred over aspirin alone), or clopidogrel 75 mg daily 3
Critical Pitfalls to Avoid
- Do NOT administer prophylactic anticonvulsants - only treat actual seizures 1
- Do NOT routinely use urgent anticoagulation - this increases hemorrhage risk without proven benefit for early recurrent stroke prevention 1
- Do NOT delay hospital notification - EMS pre-arrival notification is essential for rapid treatment 2
- Do NOT treat blood pressure aggressively unless >185/110 mmHg before tPA - permissive hypertension maintains cerebral perfusion 1, 2
- Do NOT give aspirin, heparin, or other antithrombotics within 24 hours of tPA administration 1
- Do NOT position head of bed flat if aspiration risk exists - individualize positioning based on ICP concerns versus aspiration risk 1
Systems of Care
Transport to comprehensive stroke centers when possible - these facilities have endovascular capabilities and organized stroke protocols that improve outcomes 1, 2. Regional stroke systems that expedite care increase the number of patients who can receive time-sensitive treatments 1.